Subsequently, differential expression analysis and mRNA–miRNA correlation analysis were performed to determine hsa-miR-101-3p as the upstream miRNA of EZH2 affecting the progression of patients with HCC. This evidence concerns the gene EZH2 and hepatocellular carcinoma.